BG63043B1 - Заместени 1н-имидазоли, метод за тяхното получаване и приложението им като лекарствени средства - Google Patents
Заместени 1н-имидазоли, метод за тяхното получаване и приложението им като лекарствени средства Download PDFInfo
- Publication number
- BG63043B1 BG63043B1 BG100208A BG10020895A BG63043B1 BG 63043 B1 BG63043 B1 BG 63043B1 BG 100208 A BG100208 A BG 100208A BG 10020895 A BG10020895 A BG 10020895A BG 63043 B1 BG63043 B1 BG 63043B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- imidazole
- naphthalenyl
- imidazol
- pharmaceutically acceptable
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9425211.1A GB9425211D0 (en) | 1994-12-14 | 1994-12-14 | Substituted 1H-imidazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
BG100208A BG100208A (bg) | 1996-07-31 |
BG63043B1 true BG63043B1 (bg) | 2001-02-28 |
Family
ID=10765918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG100208A BG63043B1 (bg) | 1994-12-14 | 1995-12-08 | Заместени 1н-имидазоли, метод за тяхното получаване и приложението им като лекарствени средства |
Country Status (26)
Country | Link |
---|---|
US (1) | US5658938A (no) |
EP (1) | EP0717037A1 (no) |
JP (1) | JPH08208622A (no) |
KR (1) | KR960022474A (no) |
CN (1) | CN1054376C (no) |
AR (1) | AR002257A1 (no) |
AU (1) | AU693614B2 (no) |
BG (1) | BG63043B1 (no) |
BR (1) | BR9505815A (no) |
CA (1) | CA2165133A1 (no) |
CZ (1) | CZ327195A3 (no) |
EE (1) | EE9500064A (no) |
FI (1) | FI955927A (no) |
GB (1) | GB9425211D0 (no) |
HU (1) | HUT73980A (no) |
IL (1) | IL116325A (no) |
IS (1) | IS4311A (no) |
MX (1) | MX9505063A (no) |
NO (1) | NO305316B1 (no) |
NZ (1) | NZ280646A (no) |
PL (1) | PL311736A1 (no) |
RO (1) | RO113346B1 (no) |
RU (1) | RU2156239C2 (no) |
SK (1) | SK155095A3 (no) |
TW (1) | TW303362B (no) |
ZA (1) | ZA9510554B (no) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
GB9520150D0 (en) * | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
ZA981080B (en) | 1997-02-11 | 1998-08-12 | Warner Lambert Co | Bicyclic inhibitors of protein farnesyl transferase |
US20030073850A1 (en) * | 1998-08-07 | 2003-04-17 | Altenbach Robert J. | 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use |
US6503935B1 (en) * | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
US6388090B2 (en) | 2000-01-14 | 2002-05-14 | Orion Corporation | Imidazole derivatives |
JP2003532712A (ja) | 2000-05-08 | 2003-11-05 | オリオン コーポレーション | α2アドレナリン作用活性を有する新規な多環式インダニルイミダゾール |
TW200930291A (en) * | 2002-04-29 | 2009-07-16 | Bayer Cropscience Ag | Pesticidal heterocycles |
US20040266776A1 (en) * | 2003-06-25 | 2004-12-30 | Gil Daniel W. | Methods of preventing and reducing the severity of stress-associated conditions |
FI20022007A0 (fi) * | 2002-11-08 | 2002-11-08 | Juvantia Pharma Ltd Oy | Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi |
FI20022159A0 (fi) * | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
KR20080090545A (ko) * | 2006-01-27 | 2008-10-08 | 에프. 호프만-라 로슈 아게 | Cns 장애 치료용 2-이미다졸의 용도 |
EP2076496B1 (en) * | 2006-10-19 | 2010-03-31 | F. Hoffmann-Roche AG | Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
AU2007312390B2 (en) * | 2006-10-19 | 2013-03-28 | F. Hoffmann-La Roche Ag | Aminomethyl-4-imidazoles |
CN101535292A (zh) * | 2006-11-02 | 2009-09-16 | 弗·哈夫曼-拉罗切有限公司 | 作为痕量胺相关受体的调节剂的取代的2-咪唑类化合物 |
CA2669112A1 (en) * | 2006-11-16 | 2008-05-22 | F. Hoffmann-La Roche Ag | Substituted 4-imidazoles |
CN101557810B (zh) * | 2006-12-13 | 2012-11-21 | 弗·哈夫曼-拉罗切有限公司 | 作为痕量胺相关受体(taar)的配体的新的2-咪唑类 |
US20080146523A1 (en) * | 2006-12-18 | 2008-06-19 | Guido Galley | Imidazole derivatives |
MX2009008255A (es) * | 2007-02-02 | 2009-08-12 | Hoffmann La Roche | Nuevas 2-aminooxazolinas como ligandos taar1. |
CL2008000429A1 (es) * | 2007-02-13 | 2008-08-18 | Schering Corp | Compuestos derivados de heterociclos condensados; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar afecciones asociadas con los receptores alfa2c adrenergicos, tales como congestion asociada a rinitis, polipos, resfrio |
CN101657429A (zh) * | 2007-02-13 | 2010-02-24 | 先灵公司 | 功能选择性α2C肾上腺素能受体激动剂 |
AU2008216797A1 (en) * | 2007-02-13 | 2008-08-21 | Pharmacopeia, Llc | Functionally selective alpha2C adrenoreceptor agonists |
CA2676944C (en) * | 2007-02-15 | 2016-01-19 | F. Hoffmann-La Roche Ag | 2-aminooxazolines as taar1 ligands |
JP2010531837A (ja) | 2007-07-02 | 2010-09-30 | エフ.ホフマン−ラ ロシュ アーゲー | 微量アミン関連レセプター(taar)に対して良好な親和性を有する2−イミダゾリン |
CA2691704A1 (en) * | 2007-07-03 | 2009-01-08 | F. Hoffmann-La Roche Ag | 4-imidazolines and their use as antidepressants |
AU2008281918A1 (en) * | 2007-07-27 | 2009-02-05 | F. Hoffmann-La Roche Ag | 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands |
KR20100039429A (ko) * | 2007-08-02 | 2010-04-15 | 에프. 호프만-라 로슈 아게 | Cns 질환의 치료를 위한 벤즈아미드 유도체의 용도 |
CN101784515A (zh) * | 2007-08-03 | 2010-07-21 | 弗·哈夫曼-拉罗切有限公司 | 作为taar1配体的吡啶甲酰胺和苯甲酰胺衍生物 |
CL2008003553A1 (es) * | 2007-12-05 | 2009-11-27 | Grindeks Jsc | Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso |
EP2257546B1 (en) | 2008-02-21 | 2012-08-15 | Merck Sharp & Dohme Corp. | Functionally selective alpha2c adrenoreceptor agonists |
KR101307007B1 (ko) * | 2008-07-24 | 2013-09-11 | 에프. 호프만-라 로슈 아게 | 4,5-다이하이드로-옥사졸-2-일 유도체 |
US8242153B2 (en) * | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
US20110190247A1 (en) * | 2008-08-04 | 2011-08-04 | Schering Corporation | Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
WO2010042473A1 (en) | 2008-10-07 | 2010-04-15 | Schering Corporation | Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
US20100311798A1 (en) * | 2009-06-05 | 2010-12-09 | Decoret Guillaume | 2-aminooxazolines as taar1 ligands |
US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
US8673950B2 (en) | 2010-11-02 | 2014-03-18 | Hoffmann-Laroche Inc. | Dihydrooxazol-2-amine derivatives |
US8802673B2 (en) | 2011-03-24 | 2014-08-12 | Hoffmann-La Roche Inc | Heterocyclic amine derivatives |
US9073911B2 (en) | 2011-06-09 | 2015-07-07 | Hoffmann-La Roche Inc. | Pyrazole derivatives |
US9029370B2 (en) | 2011-06-10 | 2015-05-12 | Hoffmann-La Roche Inc. | Substituted benzamide derivatives |
ES2554843T3 (es) | 2012-01-12 | 2015-12-23 | F. Hoffmann-La Roche Ag | Derivados heterocíclicos como receptores asociados de trazas de amina (TAARs) |
WO2014041007A1 (en) | 2012-09-14 | 2014-03-20 | F. Hoffmann-La Roche Ag | Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease |
BR112015001771B1 (pt) * | 2012-09-17 | 2022-08-16 | F. Hoffmann-La Roche Ag | Derivados de carboxamida de triazol, seu uso e composição farmacêutica que os compreende |
WO2015165085A1 (en) | 2014-04-30 | 2015-11-05 | F.Hoffmann-La Roche Ag | Morpholin-pyridine derivatives |
RU2017107521A (ru) | 2014-08-27 | 2018-10-01 | Ф. Хоффманн-Ля Рош Аг | Замещенные производные азетидина в качестве лигандов рецепторов следовых аминов taar |
JP6364122B2 (ja) | 2014-08-27 | 2018-07-25 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Cns障害を処置するための置換ピラジノ[2,1−a]イソキノリン誘導体 |
BR112018015389B1 (pt) | 2016-03-17 | 2023-12-19 | F. Hoffmann-La Roche Ag | Derivado de 5-etil-4-metil-pirazol-3-carboxamida, seu processo de fabricação, preparação farmacêutica oral e uso |
PL3560911T3 (pl) * | 2016-03-17 | 2021-11-22 | Fmc Corporation | Sposób konwersji enancjomeru-S do jego postaci racemicznej |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6048972A (ja) * | 1983-08-25 | 1985-03-16 | Dai Ichi Seiyaku Co Ltd | テトラヒドロナフタレン誘導体 |
GB2167408B (en) * | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
GB8626287D0 (en) * | 1986-11-04 | 1986-12-03 | Ucb Sa | Substituted 1h-imidazoles |
GB2206880B (en) * | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
US5151526A (en) * | 1990-10-11 | 1992-09-29 | The United States Of America As Represented By The Secretary Of The Army | 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic |
JPH04210680A (ja) * | 1990-12-01 | 1992-07-31 | Nissan Chem Ind Ltd | イミダゾール誘導体および植物生長調節剤 |
GB9425211D0 (en) * | 1994-12-14 | 1995-02-15 | Ucb Sa | Substituted 1H-imidazoles |
-
1994
- 1994-12-14 GB GBGB9425211.1A patent/GB9425211D0/en active Pending
-
1995
- 1995-12-05 MX MX9505063A patent/MX9505063A/es not_active IP Right Cessation
- 1995-12-08 US US08/569,947 patent/US5658938A/en not_active Expired - Fee Related
- 1995-12-08 BG BG100208A patent/BG63043B1/bg unknown
- 1995-12-08 TW TW084113098A patent/TW303362B/zh active
- 1995-12-08 IS IS4311A patent/IS4311A/is unknown
- 1995-12-08 RO RO95-02138A patent/RO113346B1/ro unknown
- 1995-12-08 PL PL95311736A patent/PL311736A1/xx unknown
- 1995-12-11 IL IL11632595A patent/IL116325A/xx not_active IP Right Cessation
- 1995-12-11 NZ NZ280646A patent/NZ280646A/en unknown
- 1995-12-11 SK SK1550-95A patent/SK155095A3/sk unknown
- 1995-12-11 FI FI955927A patent/FI955927A/fi unknown
- 1995-12-12 AR ARP950100512A patent/AR002257A1/es unknown
- 1995-12-12 EE EE9500064A patent/EE9500064A/xx unknown
- 1995-12-12 HU HU9503549A patent/HUT73980A/hu unknown
- 1995-12-12 AU AU40368/95A patent/AU693614B2/en not_active Ceased
- 1995-12-12 CZ CZ953271A patent/CZ327195A3/cs unknown
- 1995-12-12 CN CN95120834A patent/CN1054376C/zh not_active Expired - Fee Related
- 1995-12-12 NO NO955034A patent/NO305316B1/no not_active IP Right Cessation
- 1995-12-12 ZA ZA9510554A patent/ZA9510554B/xx unknown
- 1995-12-13 CA CA002165133A patent/CA2165133A1/en not_active Abandoned
- 1995-12-13 RU RU95120582/04A patent/RU2156239C2/ru active
- 1995-12-13 JP JP7324502A patent/JPH08208622A/ja active Pending
- 1995-12-13 EP EP95870132A patent/EP0717037A1/fr not_active Withdrawn
- 1995-12-13 BR BR9505815A patent/BR9505815A/pt not_active Application Discontinuation
- 1995-12-14 KR KR1019950049572A patent/KR960022474A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BG100208A (bg) | 1996-07-31 |
SK155095A3 (en) | 1997-02-05 |
FI955927A (fi) | 1996-06-15 |
EE9500064A (et) | 1996-06-17 |
NO955034L (no) | 1996-06-17 |
AU4036895A (en) | 1996-06-20 |
AR002257A1 (es) | 1998-03-11 |
CN1133837A (zh) | 1996-10-23 |
RU2156239C2 (ru) | 2000-09-20 |
JPH08208622A (ja) | 1996-08-13 |
MX9505063A (es) | 1997-01-31 |
CA2165133A1 (en) | 1996-06-15 |
EP0717037A1 (fr) | 1996-06-19 |
CZ327195A3 (en) | 1996-07-17 |
HUT73980A (en) | 1996-10-28 |
RO113346B1 (ro) | 1998-06-30 |
CN1054376C (zh) | 2000-07-12 |
FI955927A0 (fi) | 1995-12-11 |
KR960022474A (ko) | 1996-07-18 |
IL116325A (en) | 1999-10-28 |
NZ280646A (en) | 1996-08-27 |
GB9425211D0 (en) | 1995-02-15 |
PL311736A1 (en) | 1996-06-24 |
NO305316B1 (no) | 1999-05-10 |
HU9503549D0 (en) | 1996-02-28 |
ZA9510554B (en) | 1996-06-13 |
BR9505815A (pt) | 1998-01-06 |
IL116325A0 (en) | 1996-03-31 |
TW303362B (no) | 1997-04-21 |
US5658938A (en) | 1997-08-19 |
AU693614B2 (en) | 1998-07-02 |
IS4311A (is) | 1996-06-15 |
NO955034D0 (no) | 1995-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG63043B1 (bg) | Заместени 1н-имидазоли, метод за тяхното получаване и приложението им като лекарствени средства | |
DE69132340T2 (de) | Kondensiertes pyrazinderivat | |
US5001134A (en) | Piperidines, processes of preparation and medications containing them | |
DE68904586T2 (de) | Histamin-derivat, verfahren zu dessen herstellung und therapeutischen anwendung. | |
Alabaster et al. | 2 (1H)-Quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives | |
JP2840288B2 (ja) | 置換1―(1h―イミダゾール―4―イル)アルキル―ベンズアミド | |
JPS61176571A (ja) | イミダゾール誘導体およびその製造方法 | |
Chapleo et al. | Heteroaromatic analogs of the. alpha. 2-adrenoreceptor partial agonist clonidine | |
FI70580B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara n-(4-/i 3-staellning substituerad pyridyl/-piperatzinyl)alk ylazaspiro decandioner | |
EP0784055A1 (en) | Pyrimidinylpyrazole derivative | |
US6075018A (en) | 1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine derivatives | |
PL112154B1 (en) | Method of preparation of novel aminopropanol derivatives | |
JP2823620B2 (ja) | 2−ヒドロキシ−3−フェノキシ−プロピル−置換ピペラジンないしはホモピペラジン | |
SE442638B (sv) | Aminoderivat av pyrazol/1,5-a/s-triazin, forfarande for deras framstellning och farmakologisk komposition derav | |
JPS641475B2 (no) | ||
US4381302A (en) | (6aα,10aα,11aα)-2-(2-Pyridinyl)-1,3,4,6,6a,7,8,9,10,10a,11,11a-dodecahydro-2H-pyrazino]1,2-b]isoquinoline and derivatives | |
US3959476A (en) | Antihypertensive substituted triazoles | |
US6071911A (en) | 4-amino-1-arylpyridin-2-ones and process for making | |
EP0476944B1 (en) | Aromatase inhibiting 4(5)-imidazoles | |
EP0160451A2 (en) | Dihydropyridine-3,5-dicarboxylic acid ester derivative isomers, their preparation, and pharmaceutical compositions containing them | |
JP2531517B2 (ja) | ナフタレンスルホンアミド誘導体 | |
US6248907B1 (en) | N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine | |
JPS61254569A (ja) | 1,3−二置換イミダゾリウム塩 | |
JPH07165756A (ja) | ヒドロキシキノキサリンジオン誘導体 | |
US4105768A (en) | Hypotensive substituted 1,2,4-triazoles |